Log In
Print this Print this


Also known as: latanoprost/timolol (Xalacom)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionCombination of Xalatan ophthalmic solution and a beta blocker
Molecular Target Prostaglandin F (FP) receptor (PTGFR) ; Adrenergic receptor beta (ADRB)
Mechanism of ActionAdrenergic receptor beta (ADRB) antagonist; Prostaglandin F (FP) receptor agonist
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard Indication Ophthalmic (unspecified)
Indication DetailsReduce intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension not responding to topical beta-blockers
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today